RESUMEN
Inflammation, angiogenesis and cytokine production are common features of almost, if not all tumors. However, the extent of these processes induced by different types of tumors has not been evaluated. We investigated the growth pattern of the experimental metastatic tumors, B16F10 melanoma, CT26.WT colon and 4T1 mammary cells inoculated in the flank of syngeneic mice and determined the degree of inflammation, angiogenesis, and production level of pro-inflammatory and pro-angiogenic cytokines within the tumors. In addition, we have analyzed vascular changes in the interface between the tumors and the adjacent cutaneous tissue and levels of relevant pro-inflammatory and pro-angiogenic cytokines systemically. The weight of tumors 15 days post-inoculation of 10(6) cells was markedly different. Melanomas were 2 and 10-fold heavier than colon and mammary tumors, respectively. Locally, CT26.WT tumor cells induced more vessels in cutaneous tissue adjacent to the tumors but systemically, the plasma levels of VEGF were higher (approximately 2-fold) in 4T1 tumor-bearing mice compared with the other two tumors. Mammary tumors presented the most prominent inflammatory content as assessed by a range of markers (inflammatory enzymes and cytokines). The vascular index, as determined by the intra-tumor amount of hemoglobin and number of vessels in hot spot areas, was also higher (approximately 2-fold) in melanomas compared with the other two tumors. These findings showing that distinct tumor types determine differential grade of inflammation, angiogenesis and host interaction in mice may provide new insights to tailor differential therapeutic approach based on the status of tumor biomarkers.
Asunto(s)
Neoplasias del Colon/irrigación sanguínea , Inflamación/etiología , Neoplasias Mamarias Experimentales/irrigación sanguínea , Melanoma Experimental/irrigación sanguínea , Neovascularización Patológica/etiología , Animales , Biomarcadores , Neoplasias del Colon/metabolismo , Neoplasias del Colon/patología , Citocinas/biosíntesis , Citocinas/genética , Femenino , Hemoglobinas/análisis , Inflamación/sangre , Péptidos y Proteínas de Señalización Intercelular/biosíntesis , Péptidos y Proteínas de Señalización Intercelular/genética , Linfocitos Infiltrantes de Tumor , Masculino , Neoplasias Mamarias Experimentales/metabolismo , Neoplasias Mamarias Experimentales/patología , Melanoma Experimental/metabolismo , Melanoma Experimental/patología , Ratones , Ratones Endogámicos BALB C , Proteínas de Neoplasias/biosíntesis , Proteínas de Neoplasias/genética , Ácido Nítrico/metabolismo , Piel/irrigación sanguínea , Carga Tumoral , Factor de Necrosis Tumoral alfa/análisis , Factor A de Crecimiento Endotelial Vascular/sangreRESUMEN
Cystathionine beta-synthase (CBS) is a homocysteine metabolizing enzyme that contains pyridoxal phosphate (PLP) and a six-coordinate heme cofactor of unknown function. CBS was inactivated by peroxynitrite, the product of nitric oxide and superoxide radicals. The IC(50) was approximately 150microM for 5microM ferric CBS. Stopped-flow kinetics and competition experiments showed a direct reaction with a second-order rate constant of (2.4-5.0)x10(4)M(-1)s(-1) (pH 7.4, 37 degrees C). The radicals derived from peroxynitrite, nitrogen dioxide and carbonate radical, also inactivated CBS. Exposure to peroxynitrite did not modify bound PLP but led to nitration of Trp208, Trp43 and Tyr223 and alterations in the heme environment including loss of thiolate coordination, conversion to high-spin and bleaching, with no detectable formation of oxo-ferryl compounds nor promotion of one-electron processes. This study demonstrates the susceptibility of CBS to reactive oxygen/nitrogen species, with potential relevance to hyperhomocysteinemia, a risk factor for cardiovascular diseases.
Asunto(s)
Cistationina betasintasa/metabolismo , Ácido Peroxinitroso/farmacología , Dióxido de Carbono/farmacología , Cromatografía Líquida de Alta Presión , Cistationina betasintasa/química , Cistationina betasintasa/genética , Espectroscopía de Resonancia por Spin del Electrón , Activación Enzimática/efectos de los fármacos , Eliminación de Gen , Hemo/análisis , Hemo/metabolismo , Humanos , Cinética , Manitol/farmacología , Espectrometría de Masas , Ácido Nítrico/metabolismo , Ácido Peroxinitroso/metabolismo , Fenilacetatos/farmacología , Multimerización de Proteína , Estructura Cuaternaria de Proteína , Espectrofotometría Ultravioleta , Compuestos de Sulfhidrilo/metabolismoRESUMEN
Macrophage migration inhibitory factor (MIF) exerts either a protective or a deleterious role in the immune response to different pathogens. We analyzed herein the role of MIF in the host control of toxoplasmosis using MIF(-/-) mice backcrossed to either the BALB/c or the C57BL/6 genetic backgrounds. Both, wild-type (WT) BALB/c and MIF(-/-) BALB/c mice were susceptible to infection with highly virulent RH as well as moderately virulent ME49 strains of T. gondii. MIF(-/-) mice, however, showed greater liver damage and more brain cysts, produced less proinflammatory cytokines, and succumbed significantly faster than WT mice. Bone marrow-derived dendritic cells (BMDCs) from MIF(-/-) mice produced less interleukin-1beta, interleukin-12, and tumor necrosis factor-alpha than WT BMDCs after stimulation with soluble Toxoplasma antigen (STAg). Similar observations were made in CD11c(+) low-density cells isolated from the spleens of MIF(-/-) mice challenged with STAg. MIF(-/-) C57BL/6 mice succumbed to ME49 infection faster than their WT counterparts. C57BL/6 mice that succumbed to infection with the ME49 strain produced less MIF than resistant BALB/c mice similarly infected. Interestingly, an analysis of brains from patients with cerebral toxoplasmosis showed low levels of MIF expression. Together, these findings demonstrate that MIF plays a critical role in mediating host resistance against T. gondii.
Asunto(s)
Predisposición Genética a la Enfermedad , Interacciones Huésped-Parásitos , Inmunidad Innata , Oxidorreductasas Intramoleculares/fisiología , Factores Inhibidores de la Migración de Macrófagos/fisiología , Toxoplasmosis/genética , Animales , Encéfalo/metabolismo , Encéfalo/parasitología , Citocinas/biosíntesis , Células Dendríticas/inmunología , Encefalitis/inmunología , Encefalitis/parasitología , Encefalitis/patología , Hepatitis/inmunología , Hepatitis/parasitología , Hepatitis/patología , Interacciones Huésped-Parásitos/genética , Interacciones Huésped-Parásitos/inmunología , Humanos , Inmunidad Innata/genética , Oxidorreductasas Intramoleculares/genética , Factores Inhibidores de la Migración de Macrófagos/genética , Ratones , Ratones Mutantes , Ácido Nítrico/metabolismo , Receptor Toll-Like 2/biosíntesis , Toxoplasma/patogenicidad , Toxoplasmosis/inmunología , Toxoplasmosis/patología , Toxoplasmosis Cerebral/inmunología , Toxoplasmosis Cerebral/parasitología , Toxoplasmosis Cerebral/patología , VirulenciaRESUMEN
OBJECTIVE: This study was designed to determine the protective effects of a vinifera grape skins extract (GSE, 200 mg/kg/day) on the deleterious effect observed in experimental preeclampsia, a condition where reduced nitric oxide production and increase in oxidative stress are present. METHODS: A condition similar to preeclampsia was induced by chronic inhibition of nitric oxide synthesis by L-NAME (60 mg/kg/day, orally) in pregnant rats. Blood pressure (systolic, mean and diastolic) was measured with the tail cuff method on day 20 of pregnant control rats; pregnant rats treated with L-NAME, L-NAME plus GSE or GSE from day 13 to day 20 of pregnancy. Glucose was infused in anesthetized pregnant rats at day 20 and blood glucose and insulin were estimated at time zero, 15, 30, 45 and 60 minutes after beginning of glucose infusion. The number of fetus alive was also estimated at day 20 of pregnancy. In parallel, blood pressure was measured in non-pregnant and in non-pregnant rats treated with L-NAME during 7 days. RESULTS: Increase in arterial pressure, reduction of alive fetus at the end of pregnancy and increase in insulin resistance was observed in pregnant L-NAME rats but not in pregnant L-NAME plus GSE rats or in pregnant GSE rats. Increase in arterial pressure was also observed in non-pregnant L-NAME rats. CONCLUSION: The present study demonstrated a protective effect of GSE in experimental preeclampsia since the deleterious effect induced by L-NAME that is, increased in stillbirth, hypertension and insulin resistance were significantly reduced by oral treatment with the extract. Probably an endothelium-dependent vasodilator effect and an antioxidant action play an important role on the effects of GSE in experimental preeclampsia.
Asunto(s)
Fitoterapia , Extractos Vegetales/uso terapéutico , Preeclampsia/prevención & control , Vitis , Animales , Presión Sanguínea , Inhibidores Enzimáticos/farmacología , Femenino , NG-Nitroarginina Metil Éster/farmacología , Ácido Nítrico/metabolismo , Embarazo , Ratas , Ratas WistarRESUMEN
Ischemia-reperfusion (IR) liver injury is associated with temporary clamping of hepatoduodenal ligament during liver surgery, hypoperfusion shock and graft failure after liver transplantation. Mechanisms of IR liver injury include: i) loss of calcium homeostasis, ii) reactive oxygen and nitrogen species generation, iii) changes in microcirculation, iv) Kupffer cell activation, and (v) complement activation. Pre-exposure of the liver to transient ischemia increases the tolerance to IR injury, a phenomenon known as hepatic ischemic preconditioning (IP). IP involves: i) recovery of the energy supply and calcium, sodium and pH homeostasis, ii) enhancement in the antioxidant potential, and iii) expression of multiple stress-response proteins, including acute phase proteins, heat shock proteins, and heme oxygenase. These observations and preliminary studies in humans give a rationale for the assessment of IP in minimizing or preventing IR injury during surgery and non surgical conditions of tissue hypoperfusion.
Asunto(s)
Precondicionamiento Isquémico/métodos , Hígado/irrigación sanguínea , Especies Reactivas de Oxígeno/metabolismo , Daño por Reperfusión/patología , Expresión Génica , Humanos , Hígado/metabolismo , Hígado/patología , Trasplante de Hígado , Microcirculación , Ácido Nítrico/metabolismo , Estrés Oxidativo , Daño por Reperfusión/genética , Daño por Reperfusión/metabolismoRESUMEN
Brazilian flora are a source of interesting polysaccharides which, either in their native state or when submitted to structural modifications, might have potential applications as biological response modifiers (BRM). A complex acidic heteropolysaccharide, containing mainly galactose and arabinose (ARAGAL), isolated from the gum of the native leguminous tree Anadenanthera colubrina (Angico branco), was studied for its immunological properties on peritoneal exudate cells, namely their superoxide anion production, phagocytic activity, morphological alterations and percentage content of activated macrophages. Activation of macrophages showing increased cytoplasm, bright and large nuclei, various cytoplasmatic projections and spreading ability, was detected following in vitro cell exposure to ARAGAL or in cells obtained from treated animals. In vitro exposure to ARAGAL increased the occurrence of activated macrophages in a time- and a dose-dependent pattern, since approximately 82% of the cells were activated in the presence of 300 microg/ml of ARAGAL after 24 h of incubation and approximately 91% after 48 h. The occurrence of activated macrophages was also evident in cell preparations from ARAGAL-treated mice, their percentage showing a dose-dependent pattern. There were approximately 60, 75 and 75% following treatment with 100, 250 and 500 mg/kg of ARAGAL, respectively. A phagocytic assay showed that 25 microg/ml ARAGAL was sufficient to impose a maximum phagocytic ability, although this effect was dose-dependent. O(2)(-) production by macrophages from ARAGAL-treated mice was 70% higher than that of cells from untreated mice. Moreover, cells from treated mice responded to PMA, the effect being 25% higher than that of the control using untreated mice. These results thus suggest a possible role of ARAGAL from A. colubrina as a BRM.
Asunto(s)
Fabaceae/metabolismo , Macrófagos/efectos de los fármacos , Peritoneo/efectos de los fármacos , Polisacáridos/farmacología , Animales , Arabinosa/metabolismo , Galactosa/metabolismo , Macrófagos/citología , Masculino , Ratones , Ácido Nítrico/metabolismo , Peritoneo/citología , Polisacáridos/química , Polisacáridos/metabolismo , Superóxidos/metabolismo , Árboles/metabolismoRESUMEN
This study was performed using intracellular and multiunit extracellular recording techniques in order to characterize the role of nitric oxide in the afferent synaptic transmission of the vestibular system of the axolotl (Ambystoma tigrinum). Bath application of nitric oxide synthase inhibitors N(G)-nitro-L-arginine (0.01microM to 10microM) and N-nitro-L-arginine methyl ester hydrochloride (0.1microM to 1000microM) elicited a dose-dependent decrease in the basal discharge of the semicircular canal afferent fibers. N(G)-Nitro-L-arginine also diminished the response to mechanical stimuli. Moreover, N(G)-nitro-L-arginine (1microM) produced a hyperpolarization associated with a decrease in the spike discharge and diminished the frequency of the excitatory postsynaptic potentials on afferent fibers recorded intracellularly. Nitric oxide donors were also tested: (i) S-nitroso-N-acetyl-DL-penicillamine (0.1microM to 100microM) increased the basal discharge and the response to mechanical stimuli. At the maximum effective concentration (100microM) this drug affected neither the amplitude nor the frequency of the excitatory postsynaptic potentials. However, it slightly depolarized the afferent neurons and decreased their input resistance. (ii) 3-Morpholino-sydnonimine hydrochloride did not significantly affect the basal discharge or the mechanically evoked peak response of afferent neurons at any of the concentrations used (1microM to 1000microM). However, after 10min of perfusion in the bath, 1microM and 10microM 3-morpholino-sydnonimine hydrochloride significantly modified the baseline of the mechanically evoked response, producing an increase in the mean spike discharge of the afferent fibers. These results indicate that nitric oxide may have a facilitatory role on the basal discharge and on the response to mechanical stimuli of the vestibular afferent fibers. Thus, nitric oxide probably participates in the sensory coding and adaptative changes of vestibular input in normal and pathological conditions.
Asunto(s)
Células Ciliadas Vestibulares/metabolismo , Ácido Nítrico/metabolismo , Transmisión Sináptica/fisiología , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Ambystoma , Animales , Inhibidores Enzimáticos/farmacología , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Potenciales Postsinápticos Excitadores/fisiología , Molsidomina/análogos & derivados , Molsidomina/farmacología , NG-Nitroarginina Metil Éster/farmacología , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico Sintasa/metabolismo , Nitroarginina/farmacología , Penicilamina/análogos & derivados , Penicilamina/farmacología , S-Nitroso-N-Acetilpenicilamina , Sinapsis/enzimologíaRESUMEN
The present study evaluated the possible changes in the autonomic control of heart rate in the hypertensive model induced by the inhibition of nitric oxide synthase. Rats were treated with N(G)-nitro-L-arginine methyl ester (L-NAME group) in the drinking water during 7 days, whereas control groups were treated with tap water (control group) or with the N(G)-nitro-D-arginine methyl ester (D-NAME group), an inactive isomer of the L-NAME molecule. The L-NAME group developed hypertension and tachycardia. The sequential blockade of the autonomic influences with propranolol and methylatropine indicated that the intrinsic heart rate did not differ among groups and revealed a sympathetic overactivity in the control of heart rate in the L-NAME group. The spectral density power of heart rate, calculated using fast-Fourier transformation, indicated a reduced variability in the low-frequency band (0.20-0.60 Hz) for the L-NAME group. The baroreflex sensitivity was also attenuated in these animals when compared with the normotensive control or D-NAME group. Overall, these data indicate cardiac sympathetic overactivity associated with a decreased baroreflex sensitivity in L-NAME hypertensive rats.
Asunto(s)
Barorreflejo/fisiología , Corazón/inervación , Hipertensión/fisiopatología , Sistema Nervioso Simpático/fisiopatología , Animales , Antihipertensivos/farmacología , Derivados de Atropina/farmacología , Barorreflejo/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Análisis de Fourier , Corazón/fisiología , Frecuencia Cardíaca/fisiología , Hipertensión/inducido químicamente , Masculino , Miocardio/metabolismo , NG-Nitroarginina Metil Éster/farmacología , Ácido Nítrico/metabolismo , Parasimpatolíticos/farmacología , Propranolol/farmacología , Ratas , Ratas Wistar , Sistema Nervioso Simpático/efectos de los fármacos , Taquicardia/inducido químicamente , Taquicardia/fisiopatologíaRESUMEN
The most conspicuous effect of bradykinin following its administration into the systemic circulation is a transient hypotension due to vasodilation. In the present study most of the available evidence regarding the mechanisms involved in bradykinin-induced arterial vasodilation is reviewed. It has become firmly established that in most species vasodilation in response to bradykinin is mediated by the release of endothelial relaxing factors following the activation of B2-receptors. Although in some cases the action of bradykinin is entirely mediated by the endothelial release of nitric oxide (NO) and/or prostacyclin (PGI2), a large amount of evidence has been accumulated during the last 10 years indicating that a non-NO/PGI2 factor accounts for bradykinin-induced vasodilation in a wide variety of perfused vascular beds and isolated small arteries from several species including humans. Since the effect of the non-NO/PGI2 endothelium-derived relaxing factor is practically abolished by disrupting the K+ electrochemical gradient together with the fact that bradykinin causes endothelium-dependent hyperpolarization of vascular smooth muscle cells, the action of such factor has been attributed to the opening of K+ channels in these cells. The pharmacological characteristics of these channels are not uniform among the different blood vessels in which they have been examined. Although there is some evidence indicating a role for KCa or KV channels, our findings in the mesenteric bed together with other reports indicate that the K+ channels involved do not correspond exactly to any of those already described. In addition, the chemical identity of such hyperpolarizing factor is still a matter of controversy. The postulated main contenders are epoxyeicosatrienoic acids or endocannabinoid agonists for the CB1-receptors. Based on the available reports and on data from our laboratory in the rat mesenteric bed, we conclude that the NO/PGI2-independent endothelium-dependent vasodilation induced by BK is unlikely to involve a cytochrome P450 arachidonic acid metabolite or an endocannabinoid agonist.
Asunto(s)
Animales , Bradiquinina/farmacología , Factores Relajantes Endotelio-Dependientes/fisiología , Ácido Nítrico/metabolismo , Prostaglandinas/metabolismo , Vasodilatación/efectos de los fármacos , Sistema Vasomotor/efectos de los fármacos , Bradiquinina/efectos adversos , Sistema Enzimático del Citocromo P-450/metabolismo , Inhibidores Enzimáticos/metabolismo , Hipotensión/inducido químicamente , omega-N-Metilarginina/farmacología , Canales de Potasio/efectos de los fármacosRESUMEN
The most conspicuous effect of bradykinin following its administration into the systemic circulation is a transient hypotension due to vasodilation. In the present study most of the available evidence regarding the mechanisms involved in bradykinin-induced arterial vasodilation is reviewed. It has become firmly established that in most species vasodilation in response to bradykinin is mediated by the release of endothelial relaxing factors following the activation of B2-receptors. Although in some cases the action of bradykinin is entirely mediated by the endothelial release of nitric oxide (NO) and/or prostacyclin (PGI2), a large amount of evidence has been accumulated during the last 10 years indicating that a non-NO/PGI2 factor accounts for bradykinin-induced vasodilation in a wide variety of perfused vascular beds and isolated small arteries from several species including humans. Since the effect of the non-NO/PGI2 endothelium-derived relaxing factor is practically abolished by disrupting the K+ electrochemical gradient together with the fact that bradykinin causes endothelium-dependent hyperpolarization of vascular smooth muscle cells, the action of such factor has been attributed to the opening of K+ channels in these cells. The pharmacological characteristics of these channels are not uniform among the different blood vessels in which they have been examined. Although there is some evidence indicating a role for KCa or KV channels, our findings in the mesenteric bed together with other reports indicate that the K+ channels involved do not correspond exactly to any of those already described. In addition, the chemical identity of such hyperpolarizing factor is still a matter of controversy. The postulated main contenders are epoxyeicosatrienoic acids or endocannabinoid agonists for the CB1-receptors. Based on the available reports and on data from our laboratory in the rat mesenteric bed, we conclude that the NO/PGI2-independent endothelium-dependent vasodilation induced by BK is unlikely to involve a cytochrome P450 arachidonic acid metabolite or an endocannabinoid agonist.